BCIwiki (bciwiki.com) – g.tec medical engineering GmbH of Austria has registered a brain-computer interface rehabilitation trial in Parkinson's disease on ClinicalTrials.gov under the identifier NCT06690931. The entry was first posted on November 15, 2024, and was marked completed in its update of September 3, 2026.
The trial evaluates the recoveriX PRO system, according to the registration. The system combines motor imagination with functional electrical stimulation (FES) and virtual reality (VR) as feedback devices; the user wears an electroencephalography cap that registers neural activity during mental practice, and that activity drives the feedback devices. The registered questions are whether Parkinson's patients who undergo recoveriX therapy significantly improve their motor functions, whether the functional improvement achieved with the BCI treatment is superior to the standard motor imagery plus FES plus VR treatment, and whether the recoveriX-based therapy is as safe as the standard treatment.
Patients in the BCI group receive 6 sessions per week over 4 weeks of BCI training with FES and VR feedback, 24 sessions in total, the registration states, while the control group receives the same schedule of FES and VR therapy without EEG monitoring. Participants complete a full assessment before and after the intervention covering motor skills, walking ability, fatigue and the impact of the disease on activities of daily living. No results are posted in the registry entry.